Metastatic Surgery

Transcript

• 00:02For these patients who have
• 00:04metastatic prostate cancer, then the
• 00:06current standard of care is
• 00:07systemic therapy, or some so
• 00:09called the hormonal therapy,
• 00:11plus or minus chemotherapy.
• 00:13And again,
• 00:15that and those
• 00:16agents,
• 00:17are given that results of
• 00:19about a three year survival,
• 00:20median survival for these patients
• 00:22right now. So,
• 00:24what I'm trying to do
• 00:25right now in our study
• 00:27is, is that does a,
• 00:29site reduction or removing
• 00:32the local disease,
• 00:34help treat systemic disease? So
• 00:36what I mean by that
• 00:37is, is that, if we
• 00:39take out
• 00:40the site where the cancer
• 00:41came from, then will the
• 00:43hormonal therapy, will the chemotherapy
• 00:45be more effective
• 00:47against prostate cancer that has
• 00:49gone to the bones, to
• 00:50the lymph nodes, or liver,
• 00:51or other part of the
• 00:52body?